2021 was a successful year for the PHDA. Between new team members, blossoming partnerships, and innovative technologies, there is no shortage of things to celebrate.
The PHDA and AWS hosted their first co-sponsored webinar in March 2021, titled, “AWS ML and AI Tools in a Modern Healthcare Data Platform.” The webinar was presented by Dr. Gang Fu, Senior Solutions Architect on the Worldwide Public Sector Education team at AWS and focused on available AWS tools for machine learning (ML) and artificial intelligence (AI), how to use ML tools for maximum efficiency, and how to develop and launch research algorithms and models within AWS
Several former and current members of the PHDA also participated in the Precision Medicine World Conference held in Pittsburgh this past September, including Dr. Derek Angus (Aviva), Dr. Chakra Chennubhotia (SpIntellx), Dr. Phil Empey (Medivate), Dr. Carl Kingsford (Director of the CMLH), and Pradeep Ravikumar (Diagnosis Code Engine).
We featured more than 24 blog posts in 2021, highlighting the awesome work taking place by the PHDA. We were also active on social media, garnering a record-number of follows, likes, and shares on our Twitter and LinkedIn pages. The PHDA also caught up with several teams who shared a peek into their projects and progress updates this year, including the following:
- Diagnosis Coding Engine
- Realtime Evaluation for Adverse Events using Neurophysiological Monitoring (READE-IONM)
- Improving Breast Cancer with Interpretable Machine Learning
Throughout 2021, the PHDA received new proposals from researchers at Pitt and CMU. Several projects have been selected for funding and we are excited to introduce the new research topics in 2022. Keep an eye on our blog for more information.
Overall, 2021 was a great year, and we look forward to what exciting things that 2022 has in store. As always, we will continue to support new investigations led by collaborative, interdisciplinary teams and work with current teams as they take the next steps in the development and commercialization of their innovative solutions. On behalf of the PHDA, thank you for your support!